Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05989854

The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer

Currently, there are few opportunities for patients with cancer to have individual exercise guidance, and this has further been impacted by the Covid-19 pandemic. However, during the pandemic the use of virtual/remote platforms has been crucial in delivering care to cancer patients. The investigators think that remote exercise training may also offer a solution to support positive change in prostate cancer patients. As a result, the investigators have developed a remote/online exercise programme to explore this further.

This study will explore the effectiveness of an 8-week remote exercise and behavioural support intervention, and whether prostate cancer patients feel they benefit from this. The study also aims to see if this sort of exercise programme can be delivered to more prostate cancer patients in the future. This project is open to men with prostate cancer on long term hormone therapy. The intervention will be comprised of one remote supervised session per week, completed 1-1 using an online platform and up to two additional sessions, depending on its suitability for the patient, will be prescribed as unsupervised home-based exercise.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Prostate Cancer Behavior Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Motor Activity Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year–99 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

University of Surrey

Guildford, Surrey, GU2 7XH, United Kingdom

Location status: Recruiting

Location contact

Ralph J Manders, PhD

CONTACT

[email protected]

01483688668

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have had an orchiectomy OR;
  • Are receiving a GnRH agonist/antagonist OR;
  • Are currently receiving Abiraterone, Enzalutamide, Apalutamide or Darolutamide
  • Long-term retention is planned (intending to remain on the above stated treatments for at least the next 6 months).

Exclusion criteria

  • Patients who are currently classed as in active treatment i.e. are currently receiving chemotherapy/radiation therapy (Note: Patients that are included in the study but after inclusion are moved onto chemo/radiation therapy, will still be able to participate in the project).
  • Patients who are stratified as high risk for having a cardiovascular event.
  • Acute illness; or any musculoskeletal, cardiovascular or neurological disorder that could inhibit or put them at risk from exercising, as determined by screening and their clinician.
  • Men with painful or unstable bony metastases.

Treatment and study plan

Exercise

Behavioral

8 week exercise intervention, 3x/wk

Primary outcomes

  1. Functional Assessment of Cancer Therapy-Prostate

    Time frame: t= 0, 4, 8, 16 & 30 weeks

    Functional Assessment of Cancer Therapy-Prostate (FACT-P) questionnaire. Twenty-seven questions about physical, social/family, emotional and functional well-being are graded from 0-4 (0 = not at all; 4 = very much), yielding a total between 0 and 108.

  2. Functional Assessment of Cancer Therapy

    Time frame: t= 0, 4, 8, 16 & 30 weeks

    Functional Assessment of Cancer Therapy fatigue (FACIT-f) questionnaire. The FACIT-Fatigue is a validated questionnaire that was originally developed for the precise evaluation of fatigue levels in cancer patients with anemia. It consists of 13 questions using a 5 point scale (0=not at all; 1 = a little bit, 2 = somewhat, 3 = quite a bit and 4 = very much). It has been used frequently in the clinical trial setting (please see appendix 1). Responses to each question are added with equal weight to obtain a total score. The range of possible scores is 0-52, with 0 corresponding to the highest level of fatigue and 52 corresponding to the lowest level of fatigue.

Secondary outcomes

  1. Leisure time physical activity

    Time frame: t= 0, 4, 8, 16 & 30 weeks

    Godin Leisure Time Exercise Questionnaire. This is a 3 question self-report questionnaire - indirect measure of physical activity

  2. Physical activity

    Time frame: t= 0, 4, 8, 16 & 30 weeks

    The Dukes Activity Status Index. The Duke Activity Status Index (DASI) is a 12-item questionnaire that utilized self-reported physical work capacity to estimate peak metabolic equivalents (METs).

  3. Cardiovascular risk

    Time frame: t= 0, 4, 8 weeks

    Qrisk3. Estimation of cardiovascular risk based on demographical and physiological parameters

  4. Exercise adherence

    Time frame: weekly for 8 weeks

    Session adherence. The number of sessions attended, and % of scheduled sessions performed. Every exercise session either completed or not completed over the 8 week intervention period

  5. Health status

    Time frame: t= 0, 4, 8, 16 & 30 weeks

    eq-5d-5l. It comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels: no problems, slight problems, some problems, severe problems and unable to do. Each level of answer consists of each level of score ranges from 1 to 5. Each participant will have a health status consisting of 5 digits. Using the set of weights from Vietnamese population provided from the EuroGroup, we can convert each EQ-5D health state into a single summary index value. The index value ranges from 0 to 1, higher scores meaning better health quality.

Study contacts

Contact information is provided by the study sponsor or research team.

Ralph Manders, PhD

CONTACT

[email protected]

+44(0)1483688668

Sponsors and collaborators

Lead sponsor

University of Surrey

Other

Collaborators

  • Royal Surrey County Hospital NHS Foundation Trust

Registry information

Official study title

An Individualised 8-week Remote Exercise Intervention to Improve QoL, Cardiometabolic Risk and Physical Activity Level in Men With Prostate Cancer Undergoing ADT Treatment.

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 14, 2023
Registry last updated
Dec 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.